Progesterone for Miscarriage Reduction
Did you know that 3 years ago the UK became the first country in the world to recommend vaginally-administered 400mg progesterone to reduce miscarriages? It is estimated that 150,000 women each year in the UK should be taking progesterone, dubbed the “pregnancy hormone”, to reduce the risk of suffering a miscarriage. For those who didn’t …
New Equipment at the Calla Lily Labs
Delighted to have secured a number of pieces of valuable lightly-used lab equipment including these fancy Mettler-Toledo International, Inc and Sartorius analytical balances. It’s a pity for the UK that Pfizer is downsizing their labs in Sandwich, Kent – but we’re pleased to have been able to pick up some of their kit at a …
Attending the Controlled Release Society Annual Meeting
We’re delighted to have attended the Controlled Release Society‘s Annual Meeting, where 1,600 industry experts dedicated to delivery science, including delivery scientists, engineers, clinicians, and technical professionals have descended upon beautiful Bologna, Italy. We were honoured to have taken part in the Innovation Showcase where Janet Halliday shared our exciting progress with our Callavid drug …
Marielle Todd Joins as Research & Marketing Intern
We are delighted to welcome Marielle Todd to our team as a research and marketing intern. Marielle is currently pursuing her BA in Business Administration, alongside a Master of International Business at the University of Florida – Warrington College of Business. Marielle brings an academic specialisation in Entrepreneurship, coupled with valuable experience in marketing and …
Priyanka Seegobin joins as MBA Intern
We’re delighted to announce that Priyanka Seegobin has joined our team this summer as an MBA intern! Priyanka brings a wealth of experience to the table. Currently pursuing her MBA at Stanford University Graduate School of Business, she comes with five years of clinical development experience at Novo Nordisk in both drugs and device delivery. …
Attending the Decoding the Future of Women Conference
Thrilled to represent Calla Lily Clinical Care at the Decoding the Future of Women conference. It was an inspiring day filled with groundbreaking insights at the intersection of technology and women’s health. Standouts: Beyond the presentations, the conference was about connections and stories. Every innovation has a tale to tell. I had the pleasure of …
With Northwell Health in New York
Lara and I had a fantastic end to our US trip with time spent with Northwell Health, one the largest integrated health systems in the 🇺🇸. We were able to first spend the day with Drs Christine Metz and Peter K. Gregersen at The Feinstein Institutes in Manhasset. It’s always a privilege to spend any …
Presenting at the British Consulate-General’s Residence in Boston
Thang Vo-Ta and I had a series of great meetings in Boston which included the unique experience of presenting Calla Lily Clinical Care to an intimate audience at the British Consul General’s beautiful residence in Boston’s Back Bay. Thank you to Dr Peter Abbott OBE and the British Consulate-General Boston for hosting us and the …
Visiting Brigham and Women’s Hospital
It was a privilege for Lara Zibners, Co-Founder & Chairman, and I to meet with senior leadership of Brigham and Women’s Hospital in Boston led by Chief of the Division of Women’s Health Dr Kathryn Rexrode, Dr Raina Fichorova Chair in OBGYN / Vice Chair for Research, Sandra J. Butler, MPH Director of Design Impact, Dr Hadine …
Dr. Arturo Jose Mendoza Meinhardt Joins as Senior Scientist
Welcome to Arturo Jose Mendoza Meinhardt, PhD who joins our team as a Senior Scientist. Arturo is a biomaterials scientist and engineer with expertise in medical device development, analytical characterisation, and drug delivery formulations (including 18 months prior experience with our Callavid technology working as a consultant). We’re delighted to have you on-board!